VISIONIX

What VISIONIX does

VISIONIX is an ophthalmic medical device and imaging company that designs, manufactures and distributes intelligent diagnostic, screening, refraction and lens-finishing equipment for eye care professionals (opticians, optometrists and ophthalmologists). Founded in 1994 by Dr. Marc Abitbol, the company built its foundation on wavefront / Shack-Hartmann technology originally developed for astronomy, which now underpins its OCT systems (under the Optovue brand), screening devices (VX 120+, VX 130+, VX 610, VX 625, VX 650), refraction instruments (Eye Refract, VX series, Retinomax), automatic lens edgers and lensmeters (under the Briot and Weco brands), and slit lamps (MW 50D, VX 70). The portfolio covers the full clinical workflow from refraction through diagnostic imaging to in-store lens finishing, with the My VisioniXperience platform adding telehealth-enabled AI workflow and the Visionix Nexus platform managing anonymized patient data across devices.

The company's go-to-market combines direct sales operations in Europe (France, Germany, Italy, Spain, Portugal) and North America (USA, Canada) with a distributor network across Asia and South America. Revenue is generated predominantly through one-time equipment sales (with refurbished device reference prices ranging from EUR 4,700 to EUR 31,800+ indicating new-device ASPs materially higher), supplemented by a growing recurring subscription layer through the 20/20NOW tele-optometry alliance and consumables/accessories. The company claims 135,000+ eye care professionals using its products daily worldwide across multiple product categories.

In April 2026, Visionix was acquired by Revenio Group Corporation (NASDAQ Helsinki: REVXF) for an enterprise value of EUR 290 million, advised by EY-Parthenon. The deal was motivated by Revenio's identification of a EUR 1 billion market opportunity driven by aging demographics and declining healthcare workforce. Post-acquisition, Visionix was integrated with Revenio's iCare business and now operates as a wholly-owned subsidiary offering diagnostics, imaging, refraction, OCT and AI-enabled workflow solutions globally.

Name

VISIONIX

Legal name

LUNEAU SAS

Website

https://visionix.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

101–250 employees

Short description

VISIONIX designs and sells ophthalmic diagnostic, screening, refraction and lens-finishing equipment for opticians, optometrists and ophthalmologists globally, operating the Optovue, Briot and Weco brands; acquired by Revenio Group in April 2026 for EUR 290M and integrated with iCare.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Ophthalmic Goods Manufacturing (339115), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Optical Dispensing & Eyewear Devices (Frames, Lenses, Lens Edging/Finishing Equipment) (HLAHAJAD)

Keywords

• Ophthalmic medical devices
• Optical coherence tomography
• Fundus imaging systems
• Automatic lens edging
• Refraction equipment

Headquarters

HQ city

Jerusalem

HQ country

Israel

HQ region

Middle East

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Device Sales: Sale of ophthalmic diagnostic equipment including OCT systems, fundus cameras, autorefractometers, slit lamps, lens edgers, and refraction equipment to eye care professionals
2. Telehealth Platform Integration: Partnership with 20/20NOW offering tele-optometry platform services integrated with Visionix devices

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

VISIONIX designs, manufactures, and sells ophthalmic medical devices and imaging equipment for eye care professionals. Its portfolio spans Optical Coherence Tomography (OCT) systems, AI-enabled fundus cameras, refraction and screening instruments, autorefractometers, slit lamps, and automatic lens edging/finishing systems, sold under the Optovue, Briot, Weco, and Visionix brands across more than 135,000 eye care practices worldwide.

Product overview

VISIONIX is an ophthalmic medical device and imaging company offering a comprehensive portfolio of intelligent diagnostic, screening, refraction, and finishing lab equipment for Eye Care Professionals (ECPs). The company operates under multiple sub-brands: Optovue (OCT systems), Briot and Weco (automatic lens edgers), and Visionix (screening, refraction, and diagnostic instruments). Following its acquisition by Finnish company Revenio Group Corporation in April 2026, Visionix joined forces with iCare to create a stronger global eye care solutions provider. The combined entity offers diagnostics, imaging, refraction, OCT, and AI-enabled workflow solutions, with products including: Optovue Solix, Solix Essential, iScan 80, and iVue 80 OCT systems; VX 610 and VX 625 fundus cameras with integrated AI (EyeWisdom MCS-AI) for detecting 13 retinal pathologies; VX 650, VX 120+, VX 130+, and VX 110 screening devices; Eye Refract and VX series refraction instruments; Briot Couture, Emotion 3, Evolution, and Attitude 3 automatic lens edgers; Weco E7, E62, E52, E33, and E13 edgers; VX 40 and VX 36 automatic lensmeters; Retinomax and Visionix VX 90 autorefractometers; MW 50D and VX 70 slit lamps; plus the My VisioniXperience telehealth platform and Visionix Nexus data management platform. The company serves opticians, optometrists, and ophthalmologists in Europe and North America directly, and in Asia and South America through partners.

Differentiator

Problem solved

Functional benefit

Brands

• Optovue: Optical Coherence Tomography (OCT) and OCT-A devices and imaging solutions for eye care professionals
• Briot
• Weco
• Luneau Technology
• My VisioniXperience
• EyeWisdom

Products and services

• Optovue Solix Ultra-high-speed full-range spectral domain OCT system for comprehensive eye imaging from cornea to choroid, designed for ophthalmology practices requiring advanced visualization.
• Optovue Solix Essential Next-generation OCT imaging system built on spectral domain technology foundation, providing high-speed imaging from cornea to choroid at an entry-level price point.
• Optovue iScan 80
• Optovue iVue 80
• Optovue iVue 80 + iCam 12
• Optovue Autofusion Automated dual modality OCT and fundus camera combining high-speed spectral domain OCT technology with fundus imaging capabilities for ophthalmology practices.
• Visionix VX 610
• Visionix VX 625 Automatic ultra-widefield 176° fundus camera featuring True-Color technology for color-accurate retinal imaging, with automatic alignment, autofocus, automatic capture, and mosaic function enabling up to 260° field of view.
• Visionix VX 650
• Visionix VX 120+
• Visionix VX 120+ Dry Eye
• Visionix VX 130+
• Visionix VX 110
• Visionix VX 118 Anterior Segment Analyzer
• Eye Refract
• Briot Couture
• Briot Perception 3
• Briot Emotion 3
• Briot Evolution
• Briot Attitude 3
• Briot Attitude Evolution
• Visionix VX 40 Pro Auto lensmeter and lens verifier for quality control in optical retail settings, ensuring accurate lens verification.
• Weco E7
• Weco E62
• Weco E52
• Weco E33
• Weco E13
• Visionix VX 90
• Retinomax 5
• Retinomax K-Plus 5
• MW 50D Clinical
• MW 50D Digital
• Visionix VX 70
• Visionix Nexus
• My VisioniXperience Telehealth Platform

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Partnerships

Three partnerships are on record, tiered minor and core.

• EY-ParthenonminorImplementation/ SI/ Consulting Partner · 1 April 2026EY-Parthenon acted as financial advisor to Revenio Group Corporation in the acquisition of Visionix, advising on the EUR 290 million transaction.
• LT International SAScoreOthers · 1 April 2026French parent company LT International SAS sold Visionix to Revenio Group Corporation as part of the acquisition transaction. Caravelle Capital Managing Partner Charles Vilgrain participated in the press conference announcing the deal.
• 20/20NOWcoreStrategic or Co-development Partner · 13 November 2023Visionix Americas strategic alliance with 20/20NOW to bring cost-effective, in-office tele-optometry comprehensive eye exams and ocular telemedicine to more patients throughout the United States. The partnership allows Visionix to offer 20/20NOW's Tele-Optometry platform integrated with Visionix's advanced diagnostic devices. Matt Vulich, VP National Accounts at Visionix Americas, stated the companies share the same passion for helping Eye Care Professionals grow and scale their business. 20/20NOW operates in over 30 states.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Heidelberg Engineering: Specialist in OCT and confocal fundus imaging for ophthalmology, with strong academic and clinical adoption. Closely comparable to Visionix's Optovue OCT and Visionix fundus camera product lines on technology and customer base.
• Nidek Co., Ltd. Japanese manufacturer of ophthalmic diagnostic devices, autorefractors, lensmeters, and OCT systems. Directly competes with Visionix across refraction, screening, and diagnostic imaging categories.
• Topcon Healthcare: Major manufacturer of ophthalmic diagnostic equipment including OCT, fundus cameras, autorefractors, and lensmeters. Closely comparable to Visionix's OCT, refraction, and screening portfolio serving optometrists and ophthalmologists.
• Haag-Streit Group: Manufacturer of slit lamps, perimeters, and ophthalmic diagnostic instruments. Directly comparable to Visionix's slit lamp and diagnostic device portfolio serving ophthalmologists.
• Reichert Technologies (AMETEK): Manufacturer of autorefractors, lensmeters, and tonometers under the Reichert brand. Comparable to Visionix's Retinomax and Visionix VX 90 autorefractometer line.
• iCare (Revenio Group): Sister company within Revenio Group focused on tonometry and dry-eye diagnostics, now merged with Visionix. Highly comparable to Visionix's screening and diagnostic device portfolio and now a strategic partner rather than standalone competitor.
• Huvitz Co., Ltd. Korean manufacturer of autorefractors, lensmeters, and optical finishing equipment. Directly competes with Visionix's refraction and Briot/Weco lens edging product lines, particularly in Asian markets.

Emerging players

• Optopol Technology: Polish manufacturer of spectral-domain OCT systems and ophthalmic imaging devices. Direct but smaller-scale competitor to Visionix's Optovue OCT range, focused on European markets.

Broad incumbents

• Carl Zeiss Meditec: Global leader in ophthalmic devices and diagnostics including OCT, fundus imaging, perimetry, and surgical microscopy. Directly comparable to Visionix's Optovue and Visionix screening/OCT product lines but with a much broader portfolio and deeper hospital penetration.
• EssilorLuxottica: Global eyewear and lens giant with growing medical/equipment ambitions through acquisitions. Adjacent incumbent that competes with Visionix in optical retail equipment and lens finishing through its integrated channel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCbcikSPunlFDj7M3od0S_fA
• Facebookfacebook.com/817057904988470
• LinkedInlinkedin.com/company/78227
• Instagraminstagram.com/visionixfrance
• Xx.com/visionixusa

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries4 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VISIONIX